Details of the Drug
General Information of Drug (ID: DME9QR0)
| Drug Name |
S-(-)CPP
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-(4-CHLOROPHENOXY)PROPANOIC ACID; 3307-39-9; 2-(4-Chlorophenoxy)propionic acid; 4-CPP; 2-(p-Chlorophenoxy)propionic acid; 2-(4-chlorophenoxy) propionic acid; Propanoic acid, 2-(4-chlorophenoxy)-; 2-(4-CPP); C9H9ClO3; CHEBI:34603; DKHJWWRYTONYHB-UHFFFAOYSA-N; S-(-)CPP; EINECS 221-991-8; NSC 70174; alpha-(4-Chlorophenoxy)propionic acid; Propionic acid, 2-(p-chlorophenoxy)-; AC1L2CMI; C13701; NCIOpen2_003229; CHEMBL23629; SCHEMBL117259; AC1Q2C09; GTPL4098; ARONIS008729; Jsp006087; CTK4E4178; MolPort-000-685-652; NSC70174; SP4232
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 200.62 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References


